Anglo-French Drugs and Industries has built an impressive identity for itself since its humble beginnings as an importer of medicines in 1923, with over 300 products sold worldwide. The company's brands are market leaders in the nutraceuticals, CNS, skin, and respiratory segments. Our greatest strength, however, is our family of nearly 1000 people who work tirelessly to serve over 65,000 doctors, 50,000 chemists, and all of our other affiliated parties. Anglo-French Drugs & Industries Limited was founded on February 1, 1923. It is a Non-government company that is registered with the Registrar of Companies in Bangalore. It has a paid-up capital of Rs. 12,915,000 and an authorised share capital of Rs. 20,000,000. It is used in the production of other chemical products. Anglo-French Drugs & Industries Limited's Annual General Meeting (AGM) was last held on 13 August 2021, and its balance sheet was last filed on 31 March 2021, according to Ministry of Corporate Affairs (MCA) records. Uddhav Abhay Kanoria, Neha Rajen Gada, Ahmedali Nalagath, Nirbhay Abhay Kanoria, Sanatkumar Manjunath Shirali, Abhay Kanoria, Girija Subramanian, and Rakesh Parmeshwar Kanyadi are the directors of Anglo-French Drugs & Industries Limited. The Corporate Identification Number (CIN) of Anglo-French Drugs & Industries Limited is L24230KA1923PLC010205 and its registration number is 10205. Its email address is compliance@afdil.com, and its registered address is 41, 3RD CROSS, V BLOCK, RAJAJINAGAR, BANGALORE BANGALORE KA 560010 IN. The company's current status is Active.
Download Full Report
Back to unlisted shares